Cargando…
Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future
Hepatocellular carcinoma (HCC) is one of the leading indications for liver transplantation and has been the treatment of choice due to the oncologic benefit for patients with advanced chronic liver disease (AdvCLD) and small tumors for the last 25 years. For HCC patients undergoing liver transplanta...
Autores principales: | Ruch, Brianna, Wagler, Josiah, Kumm, Kayla, Zhang, Chi, Katariya, Nitin N., Garcia-Saenz-de-Sicilia, Mauricio, Giorgakis, Emmanouil, Mathur, Amit K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600271/ https://www.ncbi.nlm.nih.gov/pubmed/36290870 http://dx.doi.org/10.3390/curroncol29100593 |
Ejemplares similares
-
Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity
por: Wang, Xiaoping, et al.
Publicado: (2018) -
Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation
por: Katariya, Nitin N., et al.
Publicado: (2022) -
Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection
por: Lin, Kongying, et al.
Publicado: (2021) -
Alpha-Fetoprotein Ratio Predicts Alpha-Fetoprotein Positive Hepatocellular Cancer Patient Prognosis after Hepatectomy
por: Sun, Li-Yue, et al.
Publicado: (2022) -
Association of DGF and Early Readmissions on Outcomes Following Kidney Transplantation
por: Jadlowiec, Caroline C., et al.
Publicado: (2022)